APLS vs DHI · rev $1.00B vs P/E 9.6, rev $34.25B
Apellis Pharmaceuticals Inc (APLS) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
APLS currently screens at market cap $2.29B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the APLS and DHI stock pages for the full models.
Not investment advice.